login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
TENAX THERAPEUTICS INC (TENX) Stock News
USA
- NASDAQ:TENX -
US88032L6056
-
Common Stock
7.22
USD
+0.52 (+7.76%)
Last: 10/21/2025, 6:49:14 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
TENX Latest News, Press Relases and Analysis
All
Press Releases
a month ago - By: Tenax Therapeutics, Inc.
Tenax Therapeutics Announces European Patent Office Intention to Grant Patent Covering Use of Levosimendan in PH-HFpEF
2 months ago - By: Tenax Therapeutics, Inc.
Tenax Therapeutics to Participate in the Cantor Global Healthcare Conference 2025
2 months ago - By: The Motley Fool
Tenax Posts Wider Loss in Fiscal Q2
2 months ago - By: Tenax Therapeutics, Inc.
Tenax Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
5 months ago - By: Tenax Therapeutics, Inc.
Tenax Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
a year ago - By: BusinessInsider
TENX Stock Earnings: Tenax Therapeutics Beats EPS for Q2 2024
a year ago - By: InvestorPlace
TENX Stock Earnings: Tenax Therapeutics Beats EPS for Q2 2024
a year ago - By: InvestorPlace
Why Is Tenax Therapeutics (TENX) Stock Up 29% Today?
a year ago - By: InvestorPlace
TENX Stock Earnings: Tenax Therapeutics Misses EPS for Q1 2024
7 months ago - By: Tenax Therapeutics, Inc.
Tenax Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
7 months ago - By: Tenax Therapeutics, Inc.
Tenax Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
8 months ago - By: Tenax Therapeutics, Inc.
Tenax Therapeutics Announces $25 Million Private Placement
8 months ago - By: Tenax Therapeutics, Inc.
Tenax Therapeutics Expands Phase 3 LEVEL Program, Advancing Two TNX-103 (Oral Levosimendan) Registrational Studies for the Treatment of PH-HFpEF
9 months ago - By: Tenax Therapeutics
Tenax Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference
2 years ago - By: BusinessInsider
TENX Stock Earnings: Tenax Therapeutics Misses EPS for Q4 2023
2 years ago - By: InvestorPlace
TENX Stock Earnings: Tenax Therapeutics Misses EPS for Q4 2023
2 years ago - By: Benzinga
Tenax Therapeutics: Q4 Earnings Insights
2 years ago - By: Benzinga
Why Tenax Therapeutics (TENX) Stock Is Getting Obliterated
a year ago - By: Tenax Therapeutics
Tenax Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
a year ago - By: Tenax Therapeutics
Tenax Therapeutics to Present at the Guggenheim Healthcare Innovation Conference
a year ago - By: Tenax Therapeutics
Tenax Therapeutics Reports Second Quarter 2024 Financial Results and Provides a Corporate Update
a year ago - By: Tenax Therapeutics
Tenax Therapeutics Announces Oversubscribed $100 Million Private Placement
a year ago - By: Tenax Therapeutics
Tenax Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
2 years ago - By: InvestorPlace
- Mentions:
TIRX
HOLO
SECO
SMFL
...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
2 years ago - By: Tenax Therapeutics
Tenax Therapeutics to Host KOL Event: “LEVEL Setting: the Scientific Rationale for Levosimendan as a Potential First Treatment for PH-HFpEF, and the Ongoing Phase 3 LEVEL Study”
2 years ago - By: Tenax Therapeutics
Tenax Therapeutics Provides Business and Clinical Development Updates with Full Year 2023 Financial Results
2 years ago - By: Tenax Therapeutics
Tenax Therapeutics to Present at the 36th Annual Roth Conference
2 years ago - By: Tenax Therapeutics
Tenax Therapeutics Announces Oral Presentation of Levosimendan for the Treatment of PH-HFpEF at THT 2024
2 years ago - By: Tenax Therapeutics
Tenax Therapeutics Announces Global License Amendment that Significantly Expands Rights to Levosimendan
2 years ago - By: InvestorPlace
- Mentions:
ACB
DIS
SAVE
ACB Stock Alert: The $50 Million Reason Aurora Cannabis Is Up Today
Please enable JavaScript to continue using this application.